论文部分内容阅读
目的研究和探讨优质护理措施在脑卒中患者中的应用分析。方法选择2014年1月至2016年9月在我院就诊住院的“脑卒中”患者82例,按照数字表达法分为41例的对照组(常规护理组)和观察组41例(优质护理组)。对两组患者的治疗效果以及并发症发生情况进行比较,同时对两组患者的护理满意度进行比较。结果对照组有12例患者神经缺损及病情方面无变化,其余29例均有所好转,3例出现泌尿系统感染,3例肺部感染,2例深度静脉血栓,有效率及并发症发生率分别为70.73%、19.51%,观察组6例患者神经缺损及病情方面无变化,其余均有所好转,2例出现泌尿系统感染,1例出现肺部感染,有效率及并发症发生率分别为85.36%、7.31%,组间比有差异(P<0.05);护理方面,对照组有4例感觉不满意,3例感觉较差,满意度为82.92%,观察组仅有1例感觉不满意,满意度97.56%,组间比有差异(P<0.05)。结论为改善患者治疗效果及减少并发症为目的,对脑卒中患者采用优质护理,效果较好,得到了患者的一致认可,值得临床推广并应用。
Objective To study and explore the application of quality nursing measures in stroke patients. Methods Eighty-two “stroke” patients admitted to our hospital from January 2014 to September 2016 were divided into control group (n = 41) and observation group (n = 41) according to the digital expression method Care group). The treatment effect and complications of the two groups were compared, and the satisfaction of nursing between the two groups was compared. Results In the control group, there were 12 cases of neurological deficits and no changes in disease, the other 29 cases were improved, 3 cases of urinary tract infection, 3 cases of pulmonary infection, 2 cases of deep venous thrombosis, the effective rate and the incidence of complications Were 70.73%, 19.51%. There was no change in the neurological deficit and disease in the 6 patients in the observation group, the rest were improved, 2 cases of urinary tract infection, 1 case of pulmonary infection, the effective rate and complication rate were 85.36 % And 7.31%, respectively. There was a significant difference between the two groups (P <0.05). In nursing, 4 patients in the control group were not satisfied, 3 patients felt poor, the satisfaction was 82.92%, only 1 patient in the observation group was not satisfied, Satisfaction 97.56%, there was a difference between groups (P <0.05). Conclusions In order to improve the therapeutic effect and reduce the complication of patients, it is better to use high-quality nursing for stroke patients and get the unanimous approval of the patients, which is worthy of clinical promotion and application.